AMAG Pharmaceuticals Announces Commercial Availability of Vyleesi™ (Bremelanotide Injection)
27 août 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
The First FDA-Approved As-Needed Treatment for Premenopausal Women Experiencing Low Sexual Desire and Associated Distress Now Available to Patients WALTHAM, Mass., Aug. 27, 2019 (GLOBE NEWSWIRE)...
AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)
20 août 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Aug. 20, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a new employee of (i) an...
AMAG PHARMACEUTICALS ANNOUNCES GRANT OF INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(c)(4)
13 août 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the Board of Directors of AMAG approved inducement awards to a new employee of (i) an...
AMAG Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update
07 août 2019 07h00 HE
|
AMAG Pharmaceuticals, Inc.
Promoted products achieved sequential and year-over-year revenue and market share growth 2019 financial guidance lowered: exiting Makena intramuscular market and...
AMAG Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, August 7, 2019 at 8:00 a.m. ET
29 juil. 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., July 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2019 financial results will be released on Wednesday, August 7,...
AMAG Pharmaceuticals Announces FDA Approval of Vyleesi™ (Bremelanotide Injection) for Acquired, Generalized Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
21 juin 2019 17h23 HE
|
AMAG Pharmaceuticals, Inc.
The First FDA-Approved As-Needed Treatment for Premenopausal Women Experiencing Distress or Interpersonal Difficulty Due to Low Sexual Desire 1 in 10 Premenopausal Women in the U.S....
AMAG Pharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference
29 mai 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, president and chief executive officer, will present at the Jefferies...
AMAG Pharmaceuticals to Host Analyst Day on May 22, 2019 in New York
17 mai 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., May 17, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that it will host an Analyst Day for the investment community on Wednesday, May 22, 2019...
AMAG Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update
07 mai 2019 07h00 HE
|
AMAG Pharmaceuticals, Inc.
Achieved record Feraheme revenue growth and more than 50% market share for Makena auto-injector Completed integration of Perosphere Pharmaceuticals Inc. and progressed ciraparantag clinical program...
AMAG Pharmaceuticals Presents New Data at the American College of Obstetricians and Gynecologists Annual Meeting
03 mai 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., May 03, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that it will present new data related to investigational drug bremelanotide for the...